Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor
6 pages
English

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus
6 pages
English
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

Microlife Wins Accolades from Frost &Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor PR Newswire LONDON, Dec. 10, 2013 - Microlife's clever brand positioning and positive feedback from the validating organizations help broaden the company's market presence Based on its recent research on the blood pressure monitoring market, Frost & Sullivan presents Microlife Corporation (Microlife) with the 2013 European Frost & Sullivan Award for Competitive Strategy Innovation & Leadership. Microlife has strategically invested in R&D to address the unmet needs of a large patient base for the diagnosis of atrial fibrillation. It recently launched Watch BP Home A, an automated oscillometric blood pressure monitor equipped with an accurate atrial fibrillation detection system. The device is used at the initial level of screening for cardiovascular disorders such as hypertension and atrial fibrillation. The Watch BP Home A detects atrial fibrillation based on an embedded algorithm that calculates the irregularity index (standard deviation divided by the mean), depending on the intervals between heartbeats.

Informations

Publié par
Publié le 10 décembre 2013
Nombre de lectures 9
Langue English

Extrait

Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor

PR Newswire

- Microlife's clever brand positioning and positive feedback from the validating organizations help broaden the company's market presence

Based on its recent research on the blood pressure monitoring market, Frost & Sullivan presents Microlife Corporation (Microlife) with the 2013 European Frost & Sullivan Award for Competitive Strategy Innovation & Leadership. Microlife has strategically invested in R&D to address the unmet needs of a large patient base for the diagnosis of atrial fibrillation. It recently launched Watch BP Home A, an automated oscillometric blood pressure monitor equipped with an accurate atrial fibrillation detection system. The device is used at the initial level of screening for cardiovascular disorders such as hypertension and atrial fibrillation.

  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents